Skip to Main Navigation
Skip to Page Content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Share This:
https://ntp.niehs.nih.gov/go/3740

TDMS Study 05024-01 Pathology Tables


                                     INCIDENCE RATES OF NONNEOPLASTIC LESIONS BY ANATOMIC SITE (a)
                                                        N-METHYLOLACRYLAMIDE


NTP Experiment-Test: 05024-01                                                                                     Report: PEIRPT03
Study Type: CHRONIC                                                                                               Date: 09/04/94
Route: GAVAGE                                                                                                     Time: 03:20:11




       Facility:  Battelle Columbus Laboratory

       Chemical CAS #:  924-42-5

       Lock Date:  None

       Cage Range:  All

       Reasons For Removal:    All

       Removal Date Range:     All

       Treatment Groups:       Include All
































a  Number of animals examined microscopically at site and number of animals with lesion

                                                             Page   1

NTP Experiment-Test: 05024-01         INCIDENCE RATES OF NONNEOPLASTIC LESIONS BY ANATOMIC SITE (a)               Report: PEIRPT03
Study Type: CHRONIC                                        N-METHYLOLACRYLAMIDE                                   Date: 09/04/94  
Route: GAVAGE                                                                                                     Time: 03:20:11  
____________________________________________________________________________________________________________________________________
         FISCHER 344 RATS FEMALE                   VEHICLE      6 MG/KG      12 MG/KG                                               
                                                   CONTROL                                                                          
____________________________________________________________________________________________________________________________________
DISPOSITION SUMMARY                                                                                                                 
  Animals Initially In Study                          50           50           50                                                  
  Early Deaths                                                                                                                      
    Moribund                                          10           20           12                                                  
    Dead                                               5            8            5                                                  
  Survivors                                                                                                                         
    Terminal Sacrifice                                35           22           33                                                  
  Animals Examined Microscopically                    50           50           50                                                  
____________________________________________________________________________________________________________________________________
                                                                                                                                    
 ALIMENTARY SYSTEM                                                                                                                  
                                                                                                                                    
   Esophagus                                          (50)         (16)         (50)                                                
      Foreign Body                                                  1 (6%)       1 (2%)                                             
      Inflammation, Chronic Active                                  1 (6%)                                                          
      Inflammation, Suppurative                                                  1 (2%)                                             
   Intestine Large, Cecum                             (48)         (14)         (48)                                                
      Parasite Metazoan                                             1 (7%)                                                          
   Intestine Large, Colon                             (48)         (16)         (49)                                                
      Parasite Metazoan                                1 (2%)                    4 (8%)                                             
   Intestine Large, Rectum                            (46)         (16)         (46)                                                
      Parasite Metazoan                                3 (7%)       1 (6%)       1 (2%)                                             
   Intestine Small, Duodenum                          (49)         (16)         (50)                                                
      Diverticulum                                     1 (2%)                                                                       
   Liver                                              (50)         (21)         (50)                                                
      Angiectasis                                                                1 (2%)                                             
      Basophilic Focus                                40 (80%)      7 (33%)     37 (74%)                                            
      Clear Cell Focus                                 1 (2%)                                                                       
      Degeneration, Cystic                                                       2 (4%)                                             
      Hepatodiaphragmatic Nodule                       6 (12%)      2 (10%)      5 (10%)                                            
      Inflammation, Chronic                           27 (54%)      7 (33%)     29 (58%)                                            
      Inflammation, Necrotizing                        4 (8%)                                                                       
      Necrosis, Coagulative                            1 (2%)                    2 (4%)                                             
      Vacuolization Cytoplasmic                        2 (4%)       1 (5%)                                                          
      Portal Vein, Necrosis, Fibrinoid                 1 (2%)                                                                       
      Portal Vein, Intima, Proliferation               1 (2%)                                                                       
   Mesentery                                          (49)         (18)         (49)                                                
      Inflammation, Chronic Active                     1 (2%)       2 (11%)      1 (2%)                                             
      Necrosis                                                      2 (11%)      1 (2%)                                             
   Pancreas                                           (50)         (17)         (50)                                                
      Acinus, Atrophy                                  6 (12%)      2 (12%)     10 (20%)                                            
      Duct, Ectasia                                                              1 (2%)                                             
   Salivary Glands                                    (50)         (16)         (50)                                                
      Atrophy                                          1 (2%)                                                                       
   Stomach, Forestomach                               (49)         (16)         (50)                                                
      Inflammation, Chronic Active                     2 (4%)       1 (6%)                                                          
a  Number of animals examined microscopically at site and number of animals with lesion                                             
                                                             Page    2                                                              
NTP Experiment-Test: 05024-01         INCIDENCE RATES OF NONNEOPLASTIC LESIONS BY ANATOMIC SITE (a)               Report: PEIRPT03
Study Type: CHRONIC                                        N-METHYLOLACRYLAMIDE                                   Date: 09/04/94  
Route: GAVAGE                                                                                                     Time: 03:20:11  
____________________________________________________________________________________________________________________________________
         FISCHER 344 RATS FEMALE                   VEHICLE      6 MG/KG      12 MG/KG                                               
                                                   CONTROL                                                                          
____________________________________________________________________________________________________________________________________
                                                                                                                                    
ALIMENTARY SYSTEM - CONT                                                                                                            
      Ulcer                                            1 (2%)                                                                       
      Epithelium, Hyperplasia                                                    1 (2%)                                             
   Stomach, Glandular                                 (49)         (16)         (50)                                                
      Inflammation, Chronic Active                                  2 (13%)                                                         
      Mineralization                                                             1 (2%)                                             
____________________________________________________________________________________________________________________________________
                                                                                                                                    
 CARDIOVASCULAR SYSTEM                                                                                                              
                                                                                                                                    
   Blood Vessel                                       (50)         (16)         (47)                                                
      Pulmonary Artery, Mineralization                 1 (2%)                                                                       
   Heart                                              (50)         (16)         (50)                                                
      Cardiomyopathy, Chronic                         47 (94%)      7 (44%)     48 (96%)                                            
      Inflammation, Chronic Active                                               1 (2%)                                             
      Mineralization                                                             1 (2%)                                             
      Atrium, Thrombosis                                            1 (6%)       1 (2%)                                             
      Valve, Bacterium                                              1 (6%)       1 (2%)                                             
      Valve, Inflammation, Chronic Active                           1 (6%)                                                          
      Valve, Thrombosis                                             1 (6%)       1 (2%)                                             
____________________________________________________________________________________________________________________________________
                                                                                                                                    
 ENDOCRINE SYSTEM                                                                                                                   
                                                                                                                                    
   Adrenal Gland                                      (50)         (50)         (50)                                                
      Capsule, Inflammation, Chronic                                1 (2%)                                                          
   Adrenal Gland, Cortex                              (50)         (50)         (50)                                                
      Accessory Adrenal Cortical Nodule                1 (2%)                    1 (2%)                                             
      Cyst                                             1 (2%)                                                                       
      Degeneration, Fatty                             10 (20%)     17 (34%)     16 (32%)                                            
      Hyperplasia                                     13 (26%)     16 (32%)     18 (36%)                                            
      Hypertrophy                                      2 (4%)       5 (10%)      8 (16%)                                            
      Infiltration Cellular, Lymphocyte                             1 (2%)                                                          
   Adrenal Gland, Medulla                             (50)         (50)         (50)                                                
      Hyperplasia                                      4 (8%)       5 (10%)      6 (12%)                                            
   Pituitary Gland                                    (49)         (40)         (50)                                                
      Pars Distalis, Angiectasis                                                 6 (12%)                                            
      Pars Distalis, Cyst                             14 (29%)     10 (25%)     25 (50%)                                            
      Pars Distalis, Hyperplasia                      11 (22%)     11 (28%)     12 (24%)                                            
      Pars Intermedia, Hyperplasia                                               1 (2%)                                             
   Thyroid Gland                                      (50)         (17)         (50)                                                
      C-Cell, Hyperplasia                             20 (40%)      3 (18%)     14 (28%)                                            
____________________________________________________________________________________________________________________________________
a  Number of animals examined microscopically at site and number of animals with lesion                                             
                                                             Page    3                                                              
NTP Experiment-Test: 05024-01         INCIDENCE RATES OF NONNEOPLASTIC LESIONS BY ANATOMIC SITE (a)               Report: PEIRPT03
Study Type: CHRONIC                                        N-METHYLOLACRYLAMIDE                                   Date: 09/04/94  
Route: GAVAGE                                                                                                     Time: 03:20:11  
____________________________________________________________________________________________________________________________________
         FISCHER 344 RATS FEMALE                   VEHICLE      6 MG/KG      12 MG/KG                                               
                                                   CONTROL                                                                          
____________________________________________________________________________________________________________________________________
                                                                                                                                    
                                                                                                                                    
 GENERAL BODY SYSTEM                                                                                                                
                                                                                                                                    
   None                                                                                                                             
____________________________________________________________________________________________________________________________________
                                                                                                                                    
 GENITAL SYSTEM                                                                                                                     
                                                                                                                                    
   Clitoral Gland                                     (45)         (17)         (50)                                                
      Hyperplasia                                      1 (2%)                    1 (2%)                                             
      Inflammation, Chronic Active                     2 (4%)       1 (6%)       1 (2%)                                             
      Duct, Dilatation                                 1 (2%)                                                                       
   Ovary                                              (50)         (20)         (50)                                                
      Cyst                                             4 (8%)       4 (20%)      3 (6%)                                             
   Uterus                                             (50)         (19)         (50)                                                
      Dilatation                                       6 (12%)                   6 (12%)                                            
      Diverticulum                                                  1 (5%)       1 (2%)                                             
      Hemorrhage                                                                 1 (2%)                                             
      Inflammation, Chronic Active                     1 (2%)       2 (11%)                                                         
      Cervix, Fibrosis                                                           1 (2%)                                             
      Endometrium, Hyperplasia, Cystic, Glandular      8 (16%)      1 (5%)      14 (28%)                                            
____________________________________________________________________________________________________________________________________
                                                                                                                                    
 HEMATOPOIETIC SYSTEM                                                                                                               
                                                                                                                                    
   Bone Marrow                                        (50)         (16)         (50)                                                
      Femoral, Hyperplasia                                                       1 (2%)                                             
      Femoral, Hyperplasia, Reticulum Cell             5 (10%)      3 (19%)      3 (6%)                                             
      Femoral, Myelofibrosis                                        1 (6%)       1 (2%)                                             
      Femoral, Myeloid Cell, Hyperplasia                            1 (6%)                                                          
      Vertebral, Hyperplasia                                                     1 (2%)                                             
   Lymph Node                                         (50)         (21)         (50)                                                
      Mandibular, Hyperplasia, Plasma Cell                          1 (5%)       1 (2%)                                             
      Mandibular, Pigmentation, Hemosiderin                                      1 (2%)                                             
      Mediastinal, Inflammation, Necrotizing                        1 (5%)                                                          
      Mediastinal, Pigmentation, Hemosiderin          37 (74%)                  37 (74%)                                            
      Pancreatic, Pigmentation, Hemosiderin            1 (2%)                                                                       
   Spleen                                             (50)         (22)         (50)                                                
      Fibrosis                                                      1 (5%)                                                          
      Hematopoietic Cell Proliferation                26 (52%)      2 (9%)      32 (64%)                                            
      Pigmentation, Hemosiderin                       31 (62%)                  32 (64%)                                            
      Thrombosis                                                    1 (5%)                                                          
   Thymus                                             (38)         (16)         (41)                                                
      Cyst                                             2 (5%)                    4 (10%)                                            
____________________________________________________________________________________________________________________________________
                                                                                                                                    
a  Number of animals examined microscopically at site and number of animals with lesion                                             
                                                             Page    4                                                              
NTP Experiment-Test: 05024-01         INCIDENCE RATES OF NONNEOPLASTIC LESIONS BY ANATOMIC SITE (a)               Report: PEIRPT03
Study Type: CHRONIC                                        N-METHYLOLACRYLAMIDE                                   Date: 09/04/94  
Route: GAVAGE                                                                                                     Time: 03:20:11  
____________________________________________________________________________________________________________________________________
         FISCHER 344 RATS FEMALE                   VEHICLE      6 MG/KG      12 MG/KG                                               
                                                   CONTROL                                                                          
____________________________________________________________________________________________________________________________________
                                                                                                                                    
 INTEGUMENTARY SYSTEM                                                                                                               
                                                                                                                                    
   Mammary Gland                                      (49)         (24)         (50)                                                
      Hyperplasia, Cystic                             48 (98%)     18 (75%)     48 (96%)                                            
   Skin                                               (50)         (24)         (50)                                                
      Inflammation, Chronic Active                                               1 (2%)                                             
____________________________________________________________________________________________________________________________________
                                                                                                                                    
 MUSCULOSKELETAL SYSTEM                                                                                                             
                                                                                                                                    
   Bone                                               (50)         (16)         (50)                                                
      Femur, Fibrous Osteodystrophy                                              1 (2%)                                             
____________________________________________________________________________________________________________________________________
                                                                                                                                    
 NERVOUS SYSTEM                                                                                                                     
                                                                                                                                    
   Brain                                              (50)         (16)         (50)                                                
      Compression                                     14 (28%)      4 (25%)     13 (26%)                                            
      Hydrocephalus                                                 2 (13%)      2 (4%)                                             
      Inflammation, Chronic Active                                  1 (6%)                                                          
   Spinal Cord                                        (50)         (16)         (50)                                                
      White Matter, Degeneration                      18 (36%)                  11 (22%)                                            
____________________________________________________________________________________________________________________________________
                                                                                                                                    
 RESPIRATORY SYSTEM                                                                                                                 
                                                                                                                                    
   Lung                                               (50)         (17)         (50)                                                
      Granuloma                                                     7 (41%)      5 (10%)                                            
      Inflammation, Chronic Active                     1 (2%)                    1 (2%)                                             
      Pigmentation, Hemosiderin                                     1 (6%)                                                          
      Alveolar Epithelium, Hyperplasia                 1 (2%)                    3 (6%)                                             
   Nose                                               (50)         (16)         (50)                                                
      Inflammation, Chronic Active                     3 (6%)                    1 (2%)                                             
      Nasolacrimal Duct, Granuloma                                               1 (2%)                                             
      Nasolacrimal Duct, Inflammation, Chronic        20 (40%)                  20 (40%)                                            
      Nasolacrimal Duct, Inflammation, Suppurative     1 (2%)                    2 (4%)                                             
____________________________________________________________________________________________________________________________________
                                                                                                                                    
 SPECIAL SENSES SYSTEM                                                                                                              
                                                                                                                                    
   Eye                                                (5)          (5)          (6)                                                 
      Lens, Cataract                                   2 (40%)      2 (40%)      5 (83%)                                            
      Retina, Atrophy                                  2 (40%)      1 (20%)      3 (50%)                                            
____________________________________________________________________________________________________________________________________
                                                                                                                                    
a  Number of animals examined microscopically at site and number of animals with lesion                                             
                                                             Page    5                                                              
NTP Experiment-Test: 05024-01         INCIDENCE RATES OF NONNEOPLASTIC LESIONS BY ANATOMIC SITE (a)               Report: PEIRPT03
Study Type: CHRONIC                                        N-METHYLOLACRYLAMIDE                                   Date: 09/04/94  
Route: GAVAGE                                                                                                     Time: 03:20:11  
____________________________________________________________________________________________________________________________________
         FISCHER 344 RATS FEMALE                   VEHICLE      6 MG/KG      12 MG/KG                                               
                                                   CONTROL                                                                          
____________________________________________________________________________________________________________________________________
                                                                                                                                    
 URINARY SYSTEM                                                                                                                     
                                                                                                                                    
   Kidney                                             (50)         (17)         (50)                                                
      Bacterium                                                     1 (6%)       1 (2%)                                             
      Calculus Micro Observation Only                  2 (4%)                                                                       
      Hydronephrosis                                   2 (4%)                                                                       
      Infarct                                                       1 (6%)                                                          
      Inflammation, Chronic Active                     2 (4%)       1 (6%)       1 (2%)                                             
      Mineralization                                                             1 (2%)                                             
      Nephropathy, Chronic                            48 (96%)     11 (65%)     44 (88%)                                            
      Pigmentation, Hemosiderin                                     1 (6%)                                                          
      Renal Tubule, Atrophy                            1 (2%)                                                                       
      Transitional Epithelium, Hyperplasia             1 (2%)                                                                       
   Urinary Bladder                                    (50)         (14)         (50)                                                
      Calculus Micro Observation Only                  1 (2%)                                                                       
      Dilatation                                                    1 (7%)                                                          
      Inflammation, Chronic Active                                  1 (7%)                                                          
      Transitional Epithelium, Hyperplasia             2 (4%)       1 (7%)                                                          
                                                                                                                                    
a  Number of animals examined microscopically at site and number of animals with lesion                                             
                                                             Page    6                                                              
NTP Experiment-Test: 05024-01         INCIDENCE RATES OF NONNEOPLASTIC LESIONS BY ANATOMIC SITE (a)               Report: PEIRPT03
Study Type: CHRONIC                                        N-METHYLOLACRYLAMIDE                                   Date: 09/04/94  
Route: GAVAGE                                                                                                     Time: 03:20:11  
____________________________________________________________________________________________________________________________________
         FISCHER 344 RATS MALE                     VEHICLE      6 MG/KG      12 MG/KG                                               
                                                   CONTROL                                                                          
____________________________________________________________________________________________________________________________________
DISPOSITION SUMMARY                                                                                                                 
  Animals Initially In Study                          50           50           50                                                  
  Early Deaths                                                                                                                      
    Moribund                                          15           21           19                                                  
    Dead                                               7            7            4                                                  
  Survivors                                                                                                                         
    Terminal Sacrifice                                28           21           27                                                  
    Moribund                                                        1                                                               
  Animals Examined Microscopically                    50           50           50                                                  
____________________________________________________________________________________________________________________________________
                                                                                                                                    
 ALIMENTARY SYSTEM                                                                                                                  
                                                                                                                                    
   Esophagus                                          (50)         (16)         (50)                                                
      Foreign Body                                                  1 (6%)                                                          
      Inflammation, Necrotizing                        1 (2%)                                                                       
   Intestine Large, Colon                             (49)         (14)         (50)                                                
      Parasite Metazoan                                4 (8%)                    6 (12%)                                            
   Intestine Large, Rectum                            (49)         (15)         (49)                                                
      Inflammation, Chronic Active                                  1 (7%)                                                          
      Parasite Metazoan                                3 (6%)       1 (7%)       4 (8%)                                             
   Liver                                              (50)         (50)         (50)                                                
      Basophilic Focus                                 7 (14%)     14 (28%)      5 (10%)                                            
      Clear Cell Focus                                 1 (2%)       1 (2%)       1 (2%)                                             
      Clear Cell Focus, Multiple                                                 1 (2%)                                             
      Degeneration, Cystic                            10 (20%)      8 (16%)     19 (38%)                                            
      Eosinophilic Focus                                                         1 (2%)                                             
      Fatty Change                                     2 (4%)                                                                       
      Hepatodiaphragmatic Nodule                       2 (4%)       1 (2%)       1 (2%)                                             
      Inflammation, Chronic                            3 (6%)       7 (14%)      7 (14%)                                            
      Inflammation, Necrotizing                        1 (2%)                                                                       
      Leukocytosis                                                  1 (2%)                                                          
      Mineralization                                   1 (2%)                    1 (2%)                                             
      Necrosis, Coagulative                            2 (4%)       2 (4%)       5 (10%)                                            
      Vacuolization Cytoplasmic                        1 (2%)       4 (8%)       1 (2%)                                             
   Pancreas                                           (50)         (17)         (50)                                                
      Cyst                                                          1 (6%)                                                          
      Inflammation, Chronic                            1 (2%)                                                                       
      Pigmentation, Hemosiderin                                                  1 (2%)                                             
      Acinus, Atrophy                                 15 (30%)      9 (53%)     15 (30%)                                            
      Acinus, Hyperplasia                                                        1 (2%)                                             
      Artery, Inflammation, Proliferative                           3 (18%)                                                         
   Salivary Glands                                    (50)         (15)         (49)                                                
      Inflammation, Chronic Active                                               1 (2%)                                             
   Stomach, Forestomach                               (50)         (15)         (50)                                                
      Inflammation, Chronic Active                     2 (4%)       2 (13%)      1 (2%)                                             
a  Number of animals examined microscopically at site and number of animals with lesion                                             
                                                             Page    7                                                              
NTP Experiment-Test: 05024-01         INCIDENCE RATES OF NONNEOPLASTIC LESIONS BY ANATOMIC SITE (a)               Report: PEIRPT03
Study Type: CHRONIC                                        N-METHYLOLACRYLAMIDE                                   Date: 09/04/94  
Route: GAVAGE                                                                                                     Time: 03:20:11  
____________________________________________________________________________________________________________________________________
         FISCHER 344 RATS MALE                     VEHICLE      6 MG/KG      12 MG/KG                                               
                                                   CONTROL                                                                          
____________________________________________________________________________________________________________________________________
                                                                                                                                    
ALIMENTARY SYSTEM - CONT                                                                                                            
      Mineralization                                                             1 (2%)                                             
      Epithelium, Hyperplasia                                       1 (7%)                                                          
   Stomach, Glandular                                 (50)         (14)         (50)                                                
      Mineralization                                   1 (2%)                    3 (6%)                                             
      Necrosis, Coagulative                            1 (2%)                                                                       
   Tooth                                              (49)         (16)         (50)                                                
      Inflammation, Suppurative                        1 (2%)                                                                       
____________________________________________________________________________________________________________________________________
                                                                                                                                    
 CARDIOVASCULAR SYSTEM                                                                                                              
                                                                                                                                    
   Blood Vessel                                       (49)         (16)         (48)                                                
      Aorta, Mineralization                                                      1 (2%)                                             
      Mesenteric Artery, Mineralization                1 (2%)                                                                       
      Mesenteric Artery, Intima, Proliferation         1 (2%)                                                                       
      Pulmonary Artery, Mineralization                                           1 (2%)                                             
   Heart                                              (50)         (21)         (50)                                                
      Cardiomyopathy, Chronic                         48 (96%)     16 (76%)     48 (96%)                                            
      Infarct                                          1 (2%)                                                                       
      Mineralization                                   3 (6%)                                                                       
      Atrium, Thrombosis                               3 (6%)       6 (29%)      1 (2%)                                             
____________________________________________________________________________________________________________________________________
                                                                                                                                    
 ENDOCRINE SYSTEM                                                                                                                   
                                                                                                                                    
   Adrenal Gland, Cortex                              (50)         (50)         (50)                                                
      Accessory Adrenal Cortical Nodule                                          1 (2%)                                             
      Degeneration, Fatty                              8 (16%)     12 (24%)      9 (18%)                                            
      Hyperplasia                                     10 (20%)     10 (20%)     15 (30%)                                            
      Hypertrophy                                      1 (2%)       2 (4%)       4 (8%)                                             
      Mineralization                                                1 (2%)                                                          
      Necrosis, Coagulative                            1 (2%)                                                                       
   Adrenal Gland, Medulla                             (49)         (50)         (50)                                                
      Angiectasis                                      1 (2%)                                                                       
      Atypia Cellular                                               1 (2%)                                                          
      Hyperplasia                                     13 (27%)     24 (48%)     16 (32%)                                            
      Necrosis, Coagulative                                                      2 (4%)                                             
   Islets, Pancreatic                                 (50)         (14)         (50)                                                
      Vacuolization Cytoplasmic                                     1 (7%)                                                          
   Parathyroid Gland                                  (48)         (14)         (45)                                                
      Hyperplasia                                      1 (2%)       2 (14%)      3 (7%)                                             
   Pituitary Gland                                    (50)         (23)         (50)                                                
      Pars Distalis, Cyst                              4 (8%)       1 (4%)       2 (4%)                                             
      Pars Distalis, Hyperplasia                      18 (36%)      3 (13%)     15 (30%)                                            
      Pars Distalis, Pigmentation, Hemosiderin         1 (2%)                                                                       
      Pars Intermedia, Angiectasis                                               1 (2%)                                             
      Pars Intermedia, Cyst                            2 (4%)                    2 (4%)                                             
a  Number of animals examined microscopically at site and number of animals with lesion                                             
                                                             Page    8                                                              
NTP Experiment-Test: 05024-01         INCIDENCE RATES OF NONNEOPLASTIC LESIONS BY ANATOMIC SITE (a)               Report: PEIRPT03
Study Type: CHRONIC                                        N-METHYLOLACRYLAMIDE                                   Date: 09/04/94  
Route: GAVAGE                                                                                                     Time: 03:20:11  
____________________________________________________________________________________________________________________________________
         FISCHER 344 RATS MALE                     VEHICLE      6 MG/KG      12 MG/KG                                               
                                                   CONTROL                                                                          
____________________________________________________________________________________________________________________________________
                                                                                                                                    
ENDOCRINE SYSTEM - CONT                                                                                                             
   Thyroid Gland                                      (50)         (17)         (50)                                                
      Mineralization                                   1 (2%)                                                                       
      C-Cell, Hyperplasia                              9 (18%)      5 (29%)     17 (34%)                                            
      Follicular Cell, Hyperplasia                     1 (2%)       7 (41%)                                                         
____________________________________________________________________________________________________________________________________
                                                                                                                                    
 GENERAL BODY SYSTEM                                                                                                                
                                                                                                                                    
   None                                                                                                                             
____________________________________________________________________________________________________________________________________
                                                                                                                                    
 GENITAL SYSTEM                                                                                                                     
                                                                                                                                    
   Coagulating Gland                                  (36)         (13)         (32)                                                
      Inflammation, Chronic Active                     2 (6%)                                                                       
   Epididymis                                         (50)         (16)         (49)                                                
      Angiectasis                                                                1 (2%)                                             
      Inflammation, Chronic                                                      1 (2%)                                             
      Pigmentation, Hemosiderin                                                  1 (2%)                                             
   Preputial Gland                                    (49)         (17)         (48)                                                
      Hyperplasia                                      1 (2%)                    1 (2%)                                             
      Inflammation, Chronic Active                    42 (86%)     16 (94%)     42 (88%)                                            
   Prostate                                           (50)         (19)         (49)                                                
      Abscess                                          1 (2%)                                                                       
      Atrophy                                                                    1 (2%)                                             
      Inflammation, Chronic Active                    29 (58%)     14 (74%)     30 (61%)                                            
   Seminal Vesicle                                    (35)         (16)         (40)                                                
      Inflammation, Chronic Active                                  1 (6%)                                                          
   Testes                                             (50)         (48)         (50)                                                
      Hyperplasia                                                   2 (4%)                                                          
      Mineralization                                  17 (34%)     19 (40%)     10 (20%)                                            
      Interstitial Cell, Hyperplasia                  25 (50%)     28 (58%)     27 (54%)                                            
      Perivascular, Atrophy                                         1 (2%)                                                          
      Rete Testes, Hyperplasia                                      1 (2%)                                                          
      Seminiferous Tubule, Atrophy                    40 (80%)     40 (83%)     46 (92%)                                            
____________________________________________________________________________________________________________________________________
                                                                                                                                    
 HEMATOPOIETIC SYSTEM                                                                                                               
                                                                                                                                    
   Bone Marrow                                        (50)         (16)         (50)                                                
      Femoral, Hyperplasia                             1 (2%)                                                                       
      Femoral, Hyperplasia, Reticulum Cell             1 (2%)                    1 (2%)                                             
      Femoral, Myelofibrosis                                        1 (6%)       1 (2%)                                             
      Vertebral, Hyperplasia                           1 (2%)                                                                       
      Vertebral, Hyperplasia, Reticulum Cell                                     1 (2%)                                             
      Vertebral, Myelofibrosis                                                   1 (2%)                                             
   Lymph Node                                         (50)         (25)         (50)                                                
a  Number of animals examined microscopically at site and number of animals with lesion                                             
                                                             Page    9                                                              
NTP Experiment-Test: 05024-01         INCIDENCE RATES OF NONNEOPLASTIC LESIONS BY ANATOMIC SITE (a)               Report: PEIRPT03
Study Type: CHRONIC                                        N-METHYLOLACRYLAMIDE                                   Date: 09/04/94  
Route: GAVAGE                                                                                                     Time: 03:20:11  
____________________________________________________________________________________________________________________________________
         FISCHER 344 RATS MALE                     VEHICLE      6 MG/KG      12 MG/KG                                               
                                                   CONTROL                                                                          
____________________________________________________________________________________________________________________________________
                                                                                                                                    
HEMATOPOIETIC SYSTEM - CONT                                                                                                         
      Bronchial, Pigmentation, Hemosiderin             3 (6%)                    1 (2%)                                             
      Mandibular, Cyst                                 4 (8%)                    1 (2%)                                             
      Mandibular, Hyperplasia, Plasma Cell             3 (6%)       1 (4%)       1 (2%)                                             
      Mediastinal, Hemorrhage                          1 (2%)                                                                       
      Mediastinal, Hyperplasia, Plasma Cell                         1 (4%)                                                          
      Mediastinal, Infiltration Cellular,                                                                                           
          Histiocyte                                   1 (2%)                                                                       
      Mediastinal, Inflammation, Chronic Active                     1 (4%)                                                          
      Mediastinal, Pigmentation, Hemosiderin           1 (2%)                    2 (4%)                                             
      Renal, Hemorrhage                                1 (2%)                                                                       
      Renal, Pigmentation, Hemosiderin                                           1 (2%)                                             
   Lymph Node, Mesenteric                             (15)         (6)          (8)                                                 
      Cyst                                                          1 (17%)                                                         
      Hemorrhage                                       2 (13%)                                                                      
      Infiltration Cellular, Histiocyte                1 (7%)                                                                       
      Inflammation, Proliferative                                   1 (17%)                                                         
   Spleen                                             (50)         (47)         (50)                                                
      Fibrosis                                         5 (10%)     10 (21%)      9 (18%)                                            
      Hematopoietic Cell Proliferation                18 (36%)      1 (2%)       8 (16%)                                            
      Hyperplasia, Lymphoid                                         1 (2%)                                                          
      Infarct                                                                    1 (2%)                                             
      Infiltration Cellular, Lipocyte                  1 (2%)                                                                       
      Necrosis, Coagulative                            1 (2%)                                                                       
      Pigmentation, Hemosiderin                                                  3 (6%)                                             
   Thymus                                             (37)         (14)         (35)                                                
      Cyst                                             3 (8%)                                                                       
____________________________________________________________________________________________________________________________________
                                                                                                                                    
 INTEGUMENTARY SYSTEM                                                                                                               
                                                                                                                                    
   Mammary Gland                                      (37)         (15)         (39)                                                
      Hyperplasia, Cystic                             37 (100%)    12 (80%)     36 (92%)                                            
   Skin                                               (50)         (25)         (50)                                                
      Cyst Epithelial Inclusion                                     1 (4%)                                                          
      Fibrosis                                                                   1 (2%)                                             
      Inflammation, Chronic Active                     2 (4%)       2 (8%)                                                          
____________________________________________________________________________________________________________________________________
                                                                                                                                    
 MUSCULOSKELETAL SYSTEM                                                                                                             
                                                                                                                                    
   Bone                                               (50)         (16)         (50)                                                
      Cranium, Fibrous Osteodystrophy                  1 (2%)                    2 (4%)                                             
      Femur, Fibrous Osteodystrophy                    1 (2%)                    2 (4%)                                             
      Vertebra, Fibrous Osteodystrophy                 1 (2%)                    2 (4%)                                             
____________________________________________________________________________________________________________________________________
                                                                                                                                    
a  Number of animals examined microscopically at site and number of animals with lesion                                             
                                                             Page   10                                                              
NTP Experiment-Test: 05024-01         INCIDENCE RATES OF NONNEOPLASTIC LESIONS BY ANATOMIC SITE (a)               Report: PEIRPT03
Study Type: CHRONIC                                        N-METHYLOLACRYLAMIDE                                   Date: 09/04/94  
Route: GAVAGE                                                                                                     Time: 03:20:11  
____________________________________________________________________________________________________________________________________
         FISCHER 344 RATS MALE                     VEHICLE      6 MG/KG      12 MG/KG                                               
                                                   CONTROL                                                                          
____________________________________________________________________________________________________________________________________
                                                                                                                                    
 NERVOUS SYSTEM                                                                                                                     
                                                                                                                                    
   Brain                                              (48)         (16)         (50)                                                
      Compression                                      4 (8%)       4 (25%)      9 (18%)                                            
      Hemorrhage                                       3 (6%)       1 (6%)       1 (2%)                                             
      Hydrocephalus                                    2 (4%)       5 (31%)      2 (4%)                                             
      Inflammation, Chronic                            1 (2%)                                                                       
      Pigmentation, Hemosiderin                        1 (2%)                                                                       
      Thrombosis                                                                 1 (2%)                                             
      White Matter, Degeneration                       1 (2%)                                                                       
   Spinal Cord                                        (50)         (15)         (49)                                                
      Hemorrhage, Acute                                1 (2%)                                                                       
      White Matter, Degeneration                      19 (38%)                  21 (43%)                                            
____________________________________________________________________________________________________________________________________
                                                                                                                                    
 RESPIRATORY SYSTEM                                                                                                                 
                                                                                                                                    
   Lung                                               (50)         (17)         (49)                                                
      Bacterium                                                     1 (6%)                                                          
      Granuloma                                                     2 (12%)                                                         
      Inflammation, Chronic Active                     4 (8%)       2 (12%)      1 (2%)                                             
      Metaplasia, Osseous                                           1 (6%)                                                          
      Mineralization                                   1 (2%)                                                                       
      Alveolar Epithelium, Hyperplasia                                           1 (2%)                                             
      Alveolar Epithelium, Hyperplasia, Adenomatous    3 (6%)       2 (12%)      3 (6%)                                             
      Artery, Mediastinum, Necrosis, Fibrinoid         1 (2%)                    1 (2%)                                             
      Interstitium, Inflammation, Chronic                                        4 (8%)                                             
      Mediastinum, Inflammation, Chronic Active        1 (2%)                    1 (2%)                                             
   Nose                                               (50)         (16)         (50)                                                
      Inflammation, Chronic Active                     4 (8%)       1 (6%)       2 (4%)                                             
      Inflammation, Suppurative                                     1 (6%)                                                          
      Nasolacrimal Duct, Inflammation, Chronic        15 (30%)                  12 (24%)                                            
      Nasolacrimal Duct, Inflammation, Suppurative     4 (8%)                    3 (6%)                                             
   Trachea                                            (50)         (15)         (50)                                                
      Inflammation, Chronic Active                     1 (2%)       1 (7%)                                                          
____________________________________________________________________________________________________________________________________
                                                                                                                                    
 SPECIAL SENSES SYSTEM                                                                                                              
                                                                                                                                    
   Eye                                                (3)          (6)          (6)                                                 
      Hemorrhage                                                    1 (17%)      1 (17%)                                            
      Lens, Cataract                                   1 (33%)      1 (17%)      2 (33%)                                            
      Retina, Atrophy                                  1 (33%)      2 (33%)      2 (33%)                                            
   Harderian Gland                                    (8)          (12)         (8)                                                 
      Hemorrhage                                                                 1 (13%)                                            
____________________________________________________________________________________________________________________________________
                                                                                                                                    
a  Number of animals examined microscopically at site and number of animals with lesion                                             
                                                             Page   11                                                              
NTP Experiment-Test: 05024-01         INCIDENCE RATES OF NONNEOPLASTIC LESIONS BY ANATOMIC SITE (a)               Report: PEIRPT03
Study Type: CHRONIC                                        N-METHYLOLACRYLAMIDE                                   Date: 09/04/94  
Route: GAVAGE                                                                                                     Time: 03:20:11  
____________________________________________________________________________________________________________________________________
         FISCHER 344 RATS MALE                     VEHICLE      6 MG/KG      12 MG/KG                                               
                                                   CONTROL                                                                          
____________________________________________________________________________________________________________________________________
                                                                                                                                    
 URINARY SYSTEM                                                                                                                     
                                                                                                                                    
   Kidney                                             (50)         (36)         (50)                                                
      Cyst                                             6 (12%)      8 (22%)      6 (12%)                                            
      Hydronephrosis                                   1 (2%)                                                                       
      Inflammation, Chronic                                         1 (3%)                                                          
      Mineralization                                   1 (2%)                                                                       
      Nephropathy, Chronic                            50 (100%)    36 (100%)    50 (100%)                                           
   Urinary Bladder                                    (50)         (18)         (49)                                                
      Inflammation, Chronic Active                     1 (2%)       2 (11%)      1 (2%)                                             
      Transitional Epithelium, Hyperplasia             1 (2%)                    1 (2%)                                             
                                                                                                                                    
a  Number of animals examined microscopically at site and number of animals with lesion                                             
                                                             Page   12                                                              
                             ------------------------------------------------------------                                           
                             ----------              END OF REPORT             ----------                                           
                             ------------------------------------------------------------                                           

--multipart-boundary
Content-type: text/plain
Range: bytes 75229-75229/75229


--multipart-boundary--